EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Align Technology's enterprise value is €21,280 Mil.
Align Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €741 Mil. Therefore, Align Technology's EV-to-EBITDA for today is 28.72.
The historical rank and industry rank for Align Technology's EV-to-EBITDA or its related term are showing as below:
WBO:ALGN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.11 Med: 29.05 Max: 101.03
Current: 28.37
During the past 13 years, the highest EV-to-EBITDA of Align Technology was 101.03. The lowest was 15.11. And the median was 29.05.
WBO:ALGN's EV-to-EBITDA is ranked worse than 76.39% of 487
companies
in the Medical Devices & Instruments industry
Industry Median: 15.1
vs WBO:ALGN: 28.37
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-24), Align Technology's stock price is €291.20.
Align Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €5.397. Therefore, Align Technology's PE Ratio for today is 53.96.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Align Technology EV-to-EBITDA Historical Data
The historical data trend for Align Technology's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Align Technology's EV-to-EBITDA
For the Medical Devices subindustry, Align Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Align Technology's EV-to-EBITDA falls into.
Align Technology EV-to-EBITDA Calculation
Align Technology's EV-to-EBITDA for today is calculated as:
Align Technology's current Enterprise Value is €21,280 Mil.
Align Technology's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €741 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Align Technology's PE Ratio for today is calculated as:
Align Technology's share price for today is €291.20.
Align Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.397.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Align Technology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WBO:ALGN has been successfully added to your 